HOUSTON, TX / ACCESS Newswire / May 13, 2025 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for ...
HOUSTON, TX / ACCESS Newswire / February 18, 2025 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments ...
ST. PAUL, Minn.--(BUSINESS WIRE)-- Today, CNS Therapeutics announced the FDA approval of Gablofen® (baclofen injection) for use in the management of severe spasticity, giving healthcare providers a ...
After being largely abandoned by big pharma, biotech, and investors for well over a decade, a renewed interest, along with a surge in funding opportunities, is being seen for advanced neuroscience ...
Figure. Patient iPSC-derived neurons. (A) Typical neuron differentiation and maturation schedule including cell numbers. Batches of neuronal progenitors can be aliquoted and cryopreserved to be used ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback